Robert Hofmeister
Fortuna: - $ al 31/07/2026
Fortuna: - $ al 31/07/2026
Robert Hofmeister currently works at Molkerei Hainichen Freiberg GmbH & Co. KG, as Co-Managing Director.
Dr. Hofmeister also formerly worked at Alaunos Therapeutics, Inc., as Independent Director from 2023 to 2025, EMD Serono Research & Development Institute, Inc., as Global Head-Translational Immunotherapy from 2012 to 2015, and TCR2 Therapeutics, Inc., as Senior Vice President-Research & Development.
Dr. Hofmeister received his doctorate degree from the University of Regensburg.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/04/2025 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Molkerei Hainichen Freiberg GmbH & Co. KG
Molkerei Hainichen Freiberg GmbH & Co. KG Food: Meat/Fish/DairyConsumer Non-Durables Manufactures dairy and cheese products | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Director/Miembro de la Junta | 15/04/2025 |
| TCR2 THERAPEUTICS INC. | Director Técnico/Científico/I+D | 01/03/2022 |
EMD Serono Research & Development Institute, Inc. | Corporate Officer/Principal | 01/01/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
University of Regensburg
University of Regensburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono Research & Development Institute, Inc. | |
Molkerei Hainichen Freiberg GmbH & Co. KG
Molkerei Hainichen Freiberg GmbH & Co. KG Food: Meat/Fish/DairyConsumer Non-Durables Manufactures dairy and cheese products | Consumer Non-Durables |
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.